Latest Commercialization News

Zenith Minerals has successfully raised A$3.5 million through a fully underwritten rights issue, positioning the company to fast-track exploration and resource growth at its key gold projects in Western Australia and Queensland.

InteliCare Holdings has raised $1 million through a structured financing deal to extend its cash runway and scale its AI-driven healthcare platform across aged care and disability sectors.

Telix Pharmaceuticals has achieved a key milestone with its next-generation prostate cancer imaging agent, Gozellix, receiving a permanent HCPCS code from U.S. Medicare. This paves the way for broader reimbursement and market adoption starting October 2025.

Nanoveu Limited has showcased its acquisition of EMASS and the breakthrough ECS-DoT system-on-chip technology, promising ultra-low-power AI processing with a notable 33% simulated flight time improvement in drones.

ClearVue Technologies and LandGlass subsidiary LandVac have entered a strategic partnership to co-develop and commercialize advanced solar vacuum insulated glazing products, aiming to revolutionize energy-efficient building materials worldwide.

Challenger Gold advances its Hualilan Gold Project with final metallurgical testwork underway, confirming heap leach processing can economically recover low-grade gold previously deemed waste. This development promises to expand the project’s scale and improve its economics ahead of the full-scale Pre-Feasibility Study.

Netlinkz Limited has forged a strategic partnership with Kognitive Networks and Securelink Networks to enhance secure enterprise communication across Australia, New Zealand, and Southeast Asia using cutting-edge network management technology.

Anatara Lifesciences has strengthened its intellectual property portfolio with a Japanese patent for its GaRP gastrointestinal health product, while progressing pre-clinical studies in its Anti-Obesity Project. The company also confirmed registration of its R&D Tax Incentive application for 2024-2025.

Island Pharmaceuticals has accelerated its acquisition of the Galidesivir antiviral program from BioCryst Pharmaceuticals, adding a clinically advanced asset with significant US government backing and a promising regulatory pathway.

Sparc Technologies progresses its pioneering green hydrogen pilot plant and graphene-based coatings, backed by a significant government grant and a successful capital raise.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.

BPM Minerals has agreed to sell its Claw Gold Project to Capricorn Metals for $1.5 million upfront, with potential milestone payments doubling the deal value. This transaction strengthens BPM’s cash position to fund exploration at its promising Forelands Gold Project near Kalgoorlie.